ImmunityBio (IBRX) Acquisitions (2015)
ImmunityBio (IBRX) posted quarterly Acquisitions of $1.8 million for Q1 2015.
Powered by 
Analysis
ImmunityBio (IBRX) Acquisitions (2015) Analysis & Trends
ImmunityBio (IBRX) has reported Acquisitions for 1 consecutive years, with $1.8 million the latest figure, recorded in Q1 2015.
- In Q1 2015, Acquisitions changed N/A year-over-year to $1.8 million; the TTM figure through Dec 2015 stood at $1.8 million (changed N/A YoY), while the FY2024 annual figure was $1.0 million, changed N/A from the prior year.
- Acquisitions steadied at $1.8 million in Q1 2015 per IBRX's latest filing.
- Across five years, Acquisitions topped out at $1.8 million in Q1 2015 and bottomed at $1.8 million in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 10 | ImmunityBio | 8.45 Bn | 8.10 Bn | 50.94 Mn | - |